Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2024, quý kết thúc ngày Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Panacea Life Sciences's EPS for the twelve months ending Mar 31, 2024 was -$0.46. For fiscal 2023 it was -$0.48. The highest annual figure on record is -$0.27 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$0.48 | – |
| FY2022 | Dec 31, 2022 | -$0.62 | – |
| FY2021 | Dec 31, 2021 | -$0.27 | – |
| FY2020 | Dec 31, 2020 | -$0.31 | – |
| FY2019 | Dec 31, 2019 | -$8.40 | – |
| FY2018 | Dec 31, 2018 | -$25.48 | – |
| FY2017 | Dec 31, 2017 | -$25.48 | – |
| FY2016 | Dec 31, 2016 | -$17.92 | – |
| FY2015 | Dec 31, 2015 | -$156.80 | – |
| FY2014 | Dec 31, 2014 | -$132.16 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -$0.09 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.13 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.13 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.11 | – |
| Q1 FY2023 | Mar 31, 2023 | -$0.12 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.11 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.18 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.13 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.19 | -1050.0% |
| Q4 FY2021 | Dec 31, 2021 | -$0.13 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.14 | -450.0% |
| Q2 FY2021 | Jun 30, 2021 | $0.00 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.02 | – |
| Q3 FY2020 | Sep 30, 2020 | -$0.22 | – |
| Q2 FY2020 | Jun 30, 2020 | $0.04 | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.68 | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.53 | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.40 | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.40 | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.96 | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.07 | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.24 | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.36 | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.72 | – |
| Q4 FY2017 | Dec 31, 2017 | -$13.11 | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.48 | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.48 | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.48 | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.24 | – |
| Q2 FY2016 | Jun 30, 2016 | -$6.72 | – |
| Q1 FY2016 | Mar 31, 2016 | -$120.96 | – |
| Q4 FY2015 | Dec 31, 2015 | -$12.39 | – |
| Q1 FY2015 | Mar 31, 2015 | -$29.12 | – |
| Q4 FY2014 | Dec 31, 2014 | -$102.71 | – |
| Q3 FY2014 | Sep 30, 2014 | -$66.08 | – |
| Q2 FY2014 | Jun 30, 2014 | $0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?